799 related articles for article (PubMed ID: 14764798)
1. Induction of beta-cell rest by a Kir6.2/SUR1-selective K(ATP)-channel opener preserves beta-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose.
Ritzel RA; Hansen JB; Veldhuis JD; Butler PC
J Clin Endocrinol Metab; 2004 Feb; 89(2):795-805. PubMed ID: 14764798
[TBL] [Abstract][Full Text] [Related]
2. Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human islets.
Song SH; Rhodes CJ; Veldhuis JD; Butler PC
Endocrinology; 2003 Aug; 144(8):3399-405. PubMed ID: 12865318
[TBL] [Abstract][Full Text] [Related]
3. Glucose- and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets.
Maedler K; Størling J; Sturis J; Zuellig RA; Spinas GA; Arkhammar PO; Mandrup-Poulsen T; Donath MY
Diabetes; 2004 Jul; 53(7):1706-13. PubMed ID: 15220194
[TBL] [Abstract][Full Text] [Related]
4. Potent and selective activation of the pancreatic beta-cell type K(ATP) channel by two novel diazoxide analogues.
Dabrowski M; Larsen T; Ashcroft FM; Bondo Hansen J; Wahl P
Diabetologia; 2003 Oct; 46(10):1375-82. PubMed ID: 12961066
[TBL] [Abstract][Full Text] [Related]
5. NN414, a SUR1/Kir6.2-selective potassium channel opener, reduces blood glucose and improves glucose tolerance in the VDF Zucker rat.
Carr RD; Brand CL; Bodvarsdottir TB; Hansen JB; Sturis J
Diabetes; 2003 Oct; 52(10):2513-8. PubMed ID: 14514634
[TBL] [Abstract][Full Text] [Related]
6. The effects of NN414, a SUR1/Kir6.2 selective potassium channel opener, in healthy male subjects.
Zdravkovic M; Kruse M; Rost KL; Møss J; Kecskes A; Dyrberg T
J Clin Pharmacol; 2005 Jul; 45(7):763-72. PubMed ID: 15951466
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of hyperinsulinemia by NN414, a SUR1/Kir6.2 selective K-adenosine triphosphate channel opener, improves glucose tolerance and lipid profile in obese Zucker rats.
Alemzadeh R; Fledelius C; Bodvarsdottir T; Sturis J
Metabolism; 2004 Apr; 53(4):441-7. PubMed ID: 15045689
[TBL] [Abstract][Full Text] [Related]
8. 6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate ATP sensitive potassium channels of pancreatic beta-cells.
Nielsen FE; Bodvarsdottir TB; Worsaae A; MacKay P; Stidsen CE; Boonen HC; Pridal L; Arkhammar PO; Wahl P; Ynddal L; Junager F; Dragsted N; Tagmose TM; Mogensen JP; Koch A; Treppendahl SP; Hansen JB
J Med Chem; 2002 Sep; 45(19):4171-87. PubMed ID: 12213059
[TBL] [Abstract][Full Text] [Related]
9. The actions of a novel potent islet beta-cell specific ATP-sensitive K+ channel opener can be modulated by syntaxin-1A acting on sulfonylurea receptor 1.
Ng B; Kang Y; Elias CL; He Y; Xie H; Hansen JB; Wahl P; Gaisano HY
Diabetes; 2007 Aug; 56(8):2124-34. PubMed ID: 17496234
[TBL] [Abstract][Full Text] [Related]
10. New 3-alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-dioxide derivatives activate ATP-sensitive potassium channels of pancreatic beta cells.
Nielsen FE; Ebdrup S; Jensen AF; Ynddal L; Bodvarsdottir TB; Stidsen C; Worsaae A; Boonen HC; Arkhammar PO; Fremming T; Wahl P; Kornø HT; Hansen JB
J Med Chem; 2006 Jul; 49(14):4127-39. PubMed ID: 16821773
[TBL] [Abstract][Full Text] [Related]
11. Regulation of glucagon secretion at low glucose concentrations: evidence for adenosine triphosphate-sensitive potassium channel involvement.
Muñoz A; Hu M; Hussain K; Bryan J; Aguilar-Bryan L; Rajan AS
Endocrinology; 2005 Dec; 146(12):5514-21. PubMed ID: 16123162
[TBL] [Abstract][Full Text] [Related]
12. Regulated expression of adenosine triphosphate-sensitive potassium channel subunits in pancreatic beta-cells.
Moritz W; Leech CA; Ferrer J; Habener JF
Endocrinology; 2001 Jan; 142(1):129-38. PubMed ID: 11145575
[TBL] [Abstract][Full Text] [Related]
13. Y-26763: ATP-sensitive K+ channel activation and the inhibition of insulin release from human pancreatic beta-cells.
Cosgrove KE; Straub SG; Barnes PD; Chapman J; Sharp GW; Dunne MJ
Eur J Pharmacol; 2004 Feb; 486(2):133-9. PubMed ID: 14975702
[TBL] [Abstract][Full Text] [Related]
14. Effects of cyclooxygenase-2 inhibitor and adenosine triphosphate-sensitive potassium channel opener in syngeneic mouse islet transplantation.
Juang JH; Kuo CH
Transplant Proc; 2010 Dec; 42(10):4221-4. PubMed ID: 21168669
[TBL] [Abstract][Full Text] [Related]
15. Glucose stimulates pulsatile insulin secretion from human pancreatic islets by increasing secretory burst mass: dose-response relationships.
Ritzel RA; Veldhuis JD; Butler PC
J Clin Endocrinol Metab; 2003 Feb; 88(2):742-7. PubMed ID: 12574208
[TBL] [Abstract][Full Text] [Related]
16. Improved beta-cell survival and reduced insulitis in a type 1 diabetic rat model after treatment with a beta-cell-selective K(ATP) channel opener.
Skak K; Gotfredsen CF; Lundsgaard D; Hansen JB; Sturis J; Markholst H
Diabetes; 2004 Apr; 53(4):1089-95. PubMed ID: 15047626
[TBL] [Abstract][Full Text] [Related]
17. Overnight culture unmasks glucose-induced insulin secretion in mouse islets lacking ATP-sensitive K+ channels by improving the triggering Ca2+ signal.
Szollosi A; Nenquin M; Henquin JC
J Biol Chem; 2007 May; 282(20):14768-76. PubMed ID: 17389589
[TBL] [Abstract][Full Text] [Related]
18. Beta-cell selective K(ATP)-channel activation protects beta-cells and human islets from human islet amyloid polypeptide induced toxicity.
Ritzel RA; Jayasinghe S; Hansen JB; Sturis J; Langen R; Butler PC
Regul Pept; 2010 Dec; 165(2-3):158-62. PubMed ID: 20619299
[TBL] [Abstract][Full Text] [Related]
19. BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism.
Cosgrove KE; Antoine MH; Lee AT; Barnes PD; de Tullio P; Clayton P; McCloy R; De Lonlay P; Nihoul-Fékété C; Robert JJ; Saudubray JM; Rahier J; Lindley KJ; Hussain K; Aynsley-Green A; Pirotte B; Lebrun P; Dunne MJ
J Clin Endocrinol Metab; 2002 Nov; 87(11):4860-8. PubMed ID: 12414839
[TBL] [Abstract][Full Text] [Related]
20. The effects of NN414, a SUR1/Kir6.2 selective potassium channel opener in subjects with type 2 diabetes.
Zdravkovic M; Kruse M; Rost KL; Møss J; Kecskes A
Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):405-6. PubMed ID: 17701889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
